Respiratory_JJ Syncytial_NP Virus_NP Infection_NP Sensitizes_NP Cells_NP to_TO Apoptosis_NP Mediated_NP by_IN Tumor_NP Necrosis_NP Factor-Related_NP Apoptosis-Inducing_NP Ligand_NP Respiratory_NP syncytial_JJ virus_NN (_( RSV_NP )_) is_VBZ an_DT important_JJ cause_NN of_IN respiratory_JJ tract_NN disease_NN worldwide_RB ,_, especially_RB in_IN the_DT pediatric_JJ population_NN ._SENT For_IN viruses_NNS in_IN general_JJ ,_, apoptotic_JJ death_NN of_IN infected_JJ cells_NNS is_VBZ a_DT mechanism_NN for_IN reducing_VBG virus_NN replication_NN ._SENT Apoptosis_NN can_MD also_RB be_VB an_DT important_JJ factor_NN in_IN augmenting_VBG antigen_NN presentation_NN and_CC the_DT host_NN immune_JJ response_NN ._SENT We_PP examined_VBD apoptosis_NN in_IN response_NN to_TO RSV_NP infection_NN of_IN primary_JJ small_JJ airway_NN cells_NNS ,_, primary_JJ tracheal-bronchial_JJ cells_NNS ,_, and_CC A549_NP and_CC HEp-2_NP cell_NN lines_NNS ._SENT The_DT primary_JJ cells_NNS and_CC the_DT A549_NP cell_NN line_NN gave_VBD generally_RB similar_JJ responses_NNS ,_, indicating_VBG their_PP$ appropriateness_NN as_IN models_NNS in_IN contrast_NN to_TO HEp-2_NP cells_NNS ._SENT With_IN the_DT use_NN of_IN RNase_NP protection_NN assays_NNS with_IN probes_NNS representing_VBG 33_CD common_JJ apoptosis_NN factors_NNS ,_, we_PP found_VBD strong_JJ transcriptional_JJ activation_NN of_IN both_DT pro-_NN and_CC antiapoptotic_JJ factors_NNS in_IN response_NN to_TO RSV_NP infection_NN ,_, which_WDT were_VBD further_RBR studied_VBN at_IN the_DT protein_NN level_NN and_CC by_IN functional_JJ assays_NNS ._SENT In_IN particular_JJ ,_, RSV_NP infection_NN strongly_RB up-regulated_VBD the_DT expression_NN of_IN tumor_NN necrosis_NN factor-related_JJ apoptosis-inducing_NN ligand_NN (_( TRAIL_NP )_) and_CC its_PP$ functional_JJ receptors_NNS death_NN receptor_NN 4_CD (_( DR4_NP )_) and_CC DR5_NP ._SENT Furthermore_RB ,_, RSV-infected_NP cells_NNS became_VBD highly_RB sensitive_JJ to_TO apoptosis_NN induced_VBN by_IN exogenous_JJ TRAIL_NP ._SENT These_DT findings_NNS suggest_VBP that_IN RSV-infected_JJ cells_NNS in_IN vivo_JJ are_VBP susceptible_JJ to_TO killing_VBG through_IN the_DT TRAIL_NP pathway_NN by_IN immune_JJ cells_NNS such_JJ as_IN natural_JJ killer_NN and_CC CD4+_JJ cells_NNS that_WDT bear_VBP membrane-bound_JJ TRAIL_NN ._SENT RSV_NP infection_NN also_RB induced_VBD several_JJ proapoptotic_JJ factors_NNS of_IN the_DT Bcl-2_NP family_NN and_CC caspases_VBZ 3_CD ,_, 6_CD ,_, 7_CD ,_, 8_CD ,_, 9_CD ,_, and_CC 10_CD ,_, representing_VBG both_CC the_DT death_NN receptor-_NN and_CC mitochondrion-dependent_JJ apoptotic_JJ pathways_NNS ._SENT RSV_NP also_RB mediated_VBD the_DT strong_JJ induction_NN of_IN antiapoptotic_JJ factors_NNS of_IN the_DT Bcl-2_NP family_NN ,_, especially_RB Mcl-1_NP ,_, which_WDT might_MD account_VB for_IN the_DT delayed_JJ induction_NN of_IN apoptosis_NN in_IN RSV-infected_JJ cells_NNS in_IN the_DT absence_NN of_IN exogenous_JJ induction_NN of_IN the_DT TRAIL_NP pathway_NN ._SENT Human_JJ respiratory_JJ syncytial_JJ virus_NN (_( RSV_NP )_) is_VBZ the_DT most_RBS common_JJ cause_NN of_IN mortality_NN associated_VBN with_IN serious_JJ viral_JJ bronchiolitis_NN and_CC pneumonia_NN in_IN infants_NNS throughout_IN the_DT world_NN (_( reviewed_VBN in_IN reference_NN )_) ._SENT RSV_NP also_RB is_VBZ increasingly_RB recognized_VBN as_IN an_DT important_JJ cause_NN of_IN respiratory_JJ tract_NN disease_NN in_IN adolescents_NNS and_CC adults_NNS and_CC as_IN a_DT leading_VBG cause_NN of_IN mortality_NN associated_VBN with_IN viral_JJ pulmonary_JJ infections_NNS in_IN the_DT elderly_JJ ._SENT Currently_RB ,_, an_DT RSV_NP vaccine_NN is_VBZ not_RB yet_RB available_JJ ,_, although_IN several_JJ live_JJ attenuated_JJ vaccine_NN candidates_NNS are_VBP under_IN clinical_JJ trials_NNS ._SENT Apoptosis_NN ,_, or_CC programmed_JJ cell_NN death_NN ,_, is_VBZ a_DT common_JJ response_NN of_IN cells_NNS to_TO infection_NN with_IN viruses_NNS ._SENT Apoptosis_NN can_MD be_VB induced_VBN when_WRB specific_JJ transmembrane_NN death_NN receptors_NNS are_VBP engaged_VBN by_IN exogenous_JJ Fas_NP ligand_NN ,_, tumor_NN necrosis_NN factor_NN (_( TNF_NP )_) ,_, or_CC TNF-related_JJ apoptosis-inducing_NN ligand_NN (_( TRAIL_NN )_) borne_VBN on_IN the_DT membrane_NN of_IN effector_NN immune_JJ cells_NNS or_CC ,_, in_IN the_DT case_NN of_IN TRAIL_NP ,_, also_RB expressed_VBN as_IN a_DT secreted_VBN trimer_NN ._SENT Apoptosis_NN also_RB can_MD occur_VB when_WRB intracellular_JJ changes_NNS trigger_VBP a_DT mitochondrion-mediated_JJ pathway_NN ._SENT Each_DT pathway_NN includes_VBZ formation_NN of_IN intracellular_JJ complexes_NNS for_IN the_DT activation_NN of_IN initiator_NN caspases_NNS (_( e.g._FW ,_, caspases_NNS 8_CD ,_, 9_CD ,_, and_CC 10_CD )_) ,_, which_WDT in_IN turn_NN activate_VBP effector_NN caspases_NNS (_( e.g._FW ,_, caspases_NNS 3_CD ,_, 6_CD ,_, and_CC 7_CD )_) ,_, which_WDT in_IN turn_NN cleave_VBP cellular_JJ protein_NN substrates_NNS and_CC trigger_VB the_DT classic_JJ degenerative_JJ changes_NNS specific_JJ for_IN apoptosis_NN ._SENT In_IN some_DT situations_NNS apoptosis_NN can_MD contribute_VB to_TO pathogenesis_NN ,_, but_CC more_RBR typically_RB it_PP is_VBZ an_DT important_JJ factor_NN in_IN host_NN defense_NN that_WDT hastens_VBZ the_DT death_NN of_IN infected_JJ cells_NNS and_CC thereby_RB limits_VBZ the_DT replication_NN and_CC spread_NN of_IN the_DT virus_NN (_( see_VB reference_NN for_IN a_DT review_NN )_) ._SENT As_IN a_DT consequence_NN ,_, many_JJ viruses_NNS have_VBP evolved_VBN various_JJ mechanisms_NNS to_TO inhibit_VB or_CC evade_VB apoptosis_NN ._SENT In_IN addition_NN ,_, death_NN by_IN apoptosis_NN instead_RB of_IN necrosis_NN can_MD significantly_RB affect_VB the_DT efficiency_NN of_IN capture_NN of_IN viral_JJ antigens_NNS by_IN antigen-presenting_NN cells_NNS and_CC presentation_NN to_TO T_NN cells_NNS ._SENT The_DT most-potent_JJ antigen-presenting_NN cells_NNS ,_, dendritic_JJ cells_NNS ,_, were_VBD shown_VBN to_TO internalize_VB apoptotic_JJ but_CC not_RB necrotic_JJ cells_NNS and_CC process_VB them_PP for_IN presentation_NN by_IN both_DT major_JJ histocompatibility_NN complex_JJ class_NN I_PP and_CC class_VB II_NP molecules_NNS ;_: some_DT studies_NNS also_RB demonstrated_VBD subsequent_JJ efficient_JJ induction_NN of_IN T-cell_NN responses_NNS ._SENT For_IN example_NN ,_, loading_VBG of_IN dendritic_JJ cells_NNS with_IN human_JJ immunodeficiency_NN virus-infected_JJ apoptotic_NN ,_, but_CC not_RB necrotic_JJ ,_, cells_NNS induced_VBD proliferation_NN of_IN human_JJ immunodeficiency_NN virus-specific_JJ CD4+_NP and_CC CD8+_NP cells_NNS ._SENT In_IN the_DT context_NN of_IN virus_NN infection_NN in_IN vivo_RB ,_, a_DT recombinant_JJ rabies_NN virus_NN that_WDT was_VBD engineered_VBN to_TO express_VB cytochrome_NN c_NN ,_, an_DT effective_JJ apoptosis-inducing_NN protein_NN ,_, was_VBD associated_VBN with_IN attenuated_JJ pathogenicity_NN and_CC an_DT increased_VBN induction_NN of_IN virus-neutralizing_JJ antibodies_NNS ._SENT The_DT concept_NN that_IN apoptosis_NN can_MD play_VB a_DT significant_JJ role_NN in_IN pathogenesis_NN and_CC the_DT host_NN immune_JJ response_NN is_VBZ of_IN direct_JJ relevance_NN for_IN vaccine_NN development_NN ._SENT Information_NN concerning_VBG apoptosis_NN in_IN RSV-infected_JJ cells_NNS has_VBZ been_VBN inconsistent_JJ and_CC conflicting_JJ ._SENT Two_CD early_JJ studies_NNS identified_VBN potential_JJ mediators_NNS of_IN apoptosis_NN induced_VBN in_IN response_NN to_TO RSV_NP infection_NN ,_, namely_RB ,_, interleukin-1_JJ converting_VBG enzyme_NN and_CC Fas_NP ,_, but_CC only_RB in_IN the_DT latter_JJ study_NN was_VBD apoptosis_NN detected_VBN ,_, and_CC then_RB only_RB at_IN a_DT low_JJ level_NN ._SENT A_DT third_JJ study_NN also_RB documented_VBN elevated_JJ apoptosis_NN in_IN response_NN to_TO RSV_NP infection_NN but_CC provided_VBD evidence_NN that_IN the_DT Fas_NP pathway_NN was_VBD not_RB an_DT important_JJ mediator_NN ._SENT Instead_RB ,_, the_DT authors_NNS proposed_VBD that_IN RSV-induced_JJ apoptosis_NN is_VBZ initiated_VBN as_IN part_NN of_IN an_DT endoplasmic_JJ reticulum-associated_JJ stress_NN response_NN involving_VBG caspase_NP 12_CD ._SENT However_RB ,_, this_DT hypothesis_NN was_VBD placed_VBN in_IN doubt_NN by_IN the_DT subsequent_JJ finding_NN that_IN the_DT human_JJ caspase_NN 12_CD gene_NN contains_VBZ a_DT frameshift_NN and_CC additional_JJ loss-of-function_NN mutations_NNS that_WDT should_MD preclude_VB the_DT expression_NN of_IN functional_JJ caspase_NN 12_CD ._SENT Other_JJ recent_JJ studies_NNS implicated_VBN RSV_NP in_IN inducing_VBG antiapoptotic_JJ pathways_NNS ._SENT In_IN one_CD case_NN ,_, RSV_NP infection_NN of_IN HEp-2_NP cells_NNS induced_VBD the_DT antiapoptotic_JJ factor_NN IEX-1L_NN ._SENT In_IN a_DT second_JJ case_NN ,_, treatment_NN of_IN RSV-infected_JJ cells_NNS with_IN an_DT inhibitor_NN of_IN phosphatidylinositol_NN 3-kinase_NN (_( PI-3K_NP )_) resulted_VBD in_IN more-rapid_JJ apoptosis_NN ,_, implying_VBG that_IN under_IN normal_JJ conditions_NNS signaling_VBG through_IN the_DT PI-3K_NP pathway_NN mediates_VBZ an_DT inhibition_NN of_IN RSV-induced_JJ apoptosis_NN ._SENT The_DT idea_NN that_IN apoptosis_NN is_VBZ inhibited_VBN or_CC delayed_VBN in_IN RSV-infected_JJ cells_NNS is_VBZ consistent_JJ with_IN the_DT minimal_JJ cytopathic_JJ effect_NN observed_VBD in_IN response_NN to_TO RSV_NP infection_NN of_IN primary_JJ human_JJ airway_NN cells_NNS in_IN a_DT reconstituted_VBN differentiated_VBD pseudostratified_JJ mucociliary_JJ epithelium_NN in_IN vitro_NN ._SENT In_IN the_DT present_JJ study_NN ,_, we_PP investigated_VBD apoptosis_NN during_IN RSV_NP infection_NN ,_, in_IN particular_JJ in_IN primary_JJ cell_NN cultures_NNS as_RB well_RB as_IN in_IN transformed_VBN cell_NN lines_NNS ._SENT RNase_NP protection_NN assays_NNS (_( RPAs_NP )_) using_VBG a_DT broad_JJ panel_NN of_IN probes_NNS identified_VBN up-regulation_NN of_IN both_DT pro-_NN and_CC antiapoptotic_JJ factors_NNS ,_, representing_VBG both_CC the_DT death_NN receptor_NN and_CC mitochondrial_JJ pathways_NNS ._SENT In_IN particular_JJ ,_, RSV_NP strongly_RB up-regulated_VBD expression_NN of_IN both_DT TRAIL_NP and_CC its_PP$ functional_JJ receptors_NNS and_CC strongly_RB sensitized_VBD cells_NNS to_TO apoptosis_NN induced_VBN by_IN exogenous_JJ TRAIL_NN ._SENT In_IN the_DT absence_NN of_IN exogenous_JJ TRAIL_NP ,_, apoptosis_NN occurred_VBD very_RB late_JJ in_IN RSV_NP infection_NN ,_, a_DT delay_NN that_WDT might_MD reflect_VB the_DT strong_JJ up-regulation_NN of_IN antiapoptotic_JJ factors_NNS ,_, including_VBG Mcl-1_NP ._SENT Cells_NNS and_CC viruses_NNS ._SENT |_SYM Primary_NP normal_JJ human_JJ bronchial-tracheal_JJ epithelial_JJ cells_NNS (_( NHBE_NP )_) (_( with_IN retinoic_JJ acid_NN to_TO inhibit_VB cell_NN differentiation_NN )_) and_CC small_JJ airway_NN epithelial_JJ cells_NNS (_( SAEC_NP )_) from_IN a_DT single_JJ donor_NN were_VBD obtained_VBN from_IN Biowhittaker_NP Inc._NP (_( Walkersville_NP ,_, Md._NP )_) ._SENT The_DT cells_NNS were_VBD passaged_VBN up_RP to_TO three_CD times_NNS according_VBG to_TO the_DT manufacturer_NN 's_POS recommendations_NNS using_VBG the_DT supplied_VBN trypsin_NN and_CC medium_NN ._SENT The_DT A549_NP type_NN II_NP alveolar_JJ adenocarcinoma_NN cell_NN line_NN was_VBD obtained_VBN from_IN the_DT American_NP Type_NP Culture_NP Collection_NP (_( Manassas_NP ,_, Va._NP )_) and_CC used_VBD up_RP to_TO passage_VB 100_CD ._SENT The_DT HEp-2_NP line_NN (_( CCL-23_NP )_) was_VBD obtained_VBN from_IN the_DT American_NP Type_NP Culture_NP Collection_NP and_CC used_VBD up_RP to_TO passage_VB 400_CD ._SENT Recombinant_JJ RSV_NP strain_NN A2_NN and_CC influenza_NN A_DT virus_NN purified_VBD strain_NN H1N1_NP (_( Advanced_NP Biotechnologies_NP Inc._NP ,_, Columbia_NP ,_, Md._NP )_) were_VBD used_VBN at_IN a_DT multiplicity_NN of_IN infection_NN (_( MOI_NP )_) of_IN 2_CD PFU_NN per_IN cell_NN ._SENT Quantitation_NP of_IN RSV_NP was_VBD performed_VBN by_IN plaque_NN assay_NN using_VBG monoclonal_NN antibody_NN (_( MAb_NP )_) staining_VBG of_IN plaques_NNS ._SENT For_IN quantitation_NN of_IN intracellular_JJ RSV_NP ,_, cells_NNS were_VBD collected_VBN with_IN a_DT cell_NN scraper_NN ,_, washed_VBN ,_, resuspended_VBN in_IN a_DT small_JJ volume_NN of_IN cell_NN culture_NN medium_NN (_( 1_CD ml_NN of_IN medium_NN per_IN 106_CD cells_NNS )_) ,_, subjected_VBN to_TO freezing_VBG and_CC thawing_VBG ,_, and_CC centrifuged_VBD to_TO generate_VB a_DT clarified_VBN supernatant_JJ that_DT was_VBD quantitated_VBN by_IN plaque_NN assay_NN ._SENT For_IN some_DT experiments_NNS ,_, RSV_NP was_VBD inactivated_VBN by_IN UV_NP light_NN and_CC confirmed_VBD to_TO lack_VB residual_JJ infectivity_NN by_IN plaque_NN assay_NN ._SENT Analysis_NN of_IN mRNA_NN ._SENT |_SYM RPA_NP was_VBD done_VBN using_VBG a_DT RiboQuant_NP Multi-Probe_NP RPA_NP system_NN with_IN three_CD different_JJ mixtures_NNS of_IN probe_NN templates_NNS ,_, namely_RB ,_, hAPO-1c_NP ,_, hAPO-2b_NN ,_, and_CC hAPO-3d_NNS (_( BD_NP PharMingen_NP ,_, San_NP Diego_NP ,_, Calif._NP )_) ,_, according_VBG to_TO the_DT manufacturer_NN 's_POS recommendations_NNS ._SENT The_DT data_NNS were_VBD quantitated_VBN using_VBG a_DT PhosphorImager_NP 445-SI_NP (_( Molecular_NP Dynamics_NP ,_, Sunnyvale_NP ,_, Calif._NP )_) ._SENT For_IN RT-PCR_NP of_IN TRAIL_NP mRNA_NP ,_, total_JJ RNA_NP was_VBD subjected_VBN to_TO reverse_VB transcription_NN using_VBG a_DT random_JJ primer_NN mix_NN and_CC SuperScriptII_NP RNase_NP H-_NP reverse_JJ transcriptase_NN (_( Invitrogen_NP ,_, Carlsbad_NP ,_, Calif._NP )_) followed_VBD by_IN PCR_NP with_IN human-mouse_NP TRAIL_NP PCR_NP Primer_NP Pair_NP (_( R&D_NP Systems_NP ,_, Minneapolis_NP ,_, Minn._NP )_) and_CC Vent_NP DNA_NP polymerase_NN (_( New_NP England_NP Biolabs_NP ,_, Beverly_NP ,_, Mass._NP )_) using_VBG the_DT following_VBG parameters_NNS of_IN PCR_NP :_: melting_VBG at_IN 94C_NN for_IN 35_CD s_NNS ;_: annealing_VBG at_IN 55C_NN for_IN 35_CD s_NNS ;_: synthesis_NN of_IN DNA_NP at_IN 72C_NP for_IN 45_CD s_NNS (_( 30_CD cycles_NNS were_VBD performed_VBN )_) ._SENT Flow_NN cytometry_NN analyses_NNS ._SENT |_SYM Annexin_NP V_CD staining_VBG was_VBD performed_VBN using_VBG fluorescein_NN isothiocyanate_NN (FITC)-labeled_VBN annexin_NP V_CD (_( BD_NP Biosciences_NP ,_, San_NP Diego_NP ,_, Calif._NP )_) according_VBG to_TO the_DT manufacturer_NN 's_POS recommendations_NNS ._SENT Terminal_JJ deoxynucleotidyltransferase_NN dUTP_NN nick_NN end_NN labeling_VBG (_( TUNEL_NP )_) assay_NN was_VBD performed_VBN using_VBG FlowTACS_NP In_IN Situ_NP TUNEL-based_JJ apoptosis_NN detection_NN kit_NN (_( R&D_NP Systems_NPS )_) according_VBG to_TO the_DT manufacturer_NN 's_POS recommendations_NNS ._SENT For_IN flow_NN cytometry_NN analysis_NN of_IN cell_NN surface_NN TRAIL_NN ,_, cells_NNS were_VBD stained_VBN with_IN primary_JJ anti-human_NP TRAIL_NP MAb_NP 687_CD or_CC mouse_NN MAb_NP 002_CD (_( isotype_NN control_NN )_) (_( both_CC from_IN R&D_NP Systems_NPS )_) ,_, followed_VBN by_IN secondary_JJ antibody_NN ,_, R-phycoerythrin_NP (R-PE)-labeled_JJ goat_NN anti-mouse_NN immunoglobulin_NN G_NP (_( IgG_NP )_) (_( Caltag_NP Laboratories_NP ,_, Burlingame_NP ,_, Calif._NP )_) ._SENT Death_NN receptor_NN 4_CD (_( DR4_NP )_) expression_NN was_VBD analyzed_VBN using_VBG goat_NN polyclonal_JJ IgG_NP specific_NN to_TO extracellular_JJ domain_NN of_IN human_JJ DR4_NP or_CC normal_JJ goat_NN IgG_NP (_( isotype_NN control_NN )_) (_( both_CC from_IN R&D_NP Systems_NPS )_) ,_, followed_VBN by_IN R-PE-labeled_JJ swine_NN anti-goat_NN IgG_NP (_( Caltag_NP Laboratories_NPS )_) ._SENT DR5_NP was_VBD analyzed_VBN using_VBG goat_NN polyclonal_JJ IgG_NP specific_NN to_TO extracellular_JJ domain_NN of_IN human_JJ DR5_NP (_( R&D_NP Systems_NPS )_) ._SENT For_IN quantitation_NN of_IN intracellular_JJ Mcl-1_NP by_IN flow_NN cytometry_NN ,_, cells_NNS were_VBD fixed_VBN and_CC permeabilized_VBN using_VBG a_DT DAKO_NP IntraStain_NP fixation_NN and_CC permeabilization_NN kit_NN (_( DAKO_NP Corporation_NP ,_, Carpinteria_NP ,_, Calif._NP )_) and_CC stained_VBN with_IN human_JJ Mcl-1-specific_NP purified_VBD rabbit_NN polyclonal_JJ IgG_NP or_CC ,_, as_IN a_DT control_NN ,_, normal_JJ rabbit_NN IgG_NP (_( both_CC from_IN Santa_NP Cruz_NP Biotechnology_NP ,_, Inc._NP ,_, Santa_NP Cruz_NP ,_, Calif._NP )_) ,_, and_CC this_DT was_VBD followed_VBN by_IN staining_VBG with_IN FITC-labeled_JJ goat_NN anti-rabbit_NN IgG_NP (_( Caltag_NP Laboratories_NPS )_) ._SENT Analysis_NN of_IN enzymatic_JJ activity_NN of_IN caspases_NNS ._SENT |_SYM Analysis_NN of_IN caspase_NN activity_NN was_VBD performed_VBN using_VBG the_DT pan-caspase_NN inhibitor_NN valyl-alanyl-aspartyl_NN fluoromethyl_NN ketone_NN (_( VAD-FMK_NP )_) conjugated_VBD with_IN FITC_NP (_( Promega_NP ,_, Madison_NP ,_, Wis._NP )_) ._SENT A_DT total_NN of_IN 500,000_CD cells_NNS were_VBD labeled_VBN with_IN 10_CD mul_NN of_IN a_DT 1:50_CD dilution_NN of_IN FITC-VAD-FMK_NP for_IN 20_CD min_NN at_IN 37C_JJ ,_, followed_VBN by_IN flow_NN cytometry_NN ._SENT For_IN analysis_NN of_IN enzymatic_JJ activities_NNS of_IN individual_JJ caspases_NNS ,_, cell_NN lysates_NNS were_VBD prepared_VBN and_CC normalized_VBN according_VBG to_TO protein_NN concentration_NN determined_VBD using_VBG the_DT BCA_NP Protein_NP Assay_NP reagent_NN kit_NN (_( Pierce_NP ,_, Rockford_NP ,_, Ill._NP )_) ._SENT Analysis_NN was_VBD performed_VBN using_VBG caspases_NNS 8_CD ,_, 3_CD ,_, 6_CD ,_, and_CC 9_CD (_( Colorimetric_JJ activity_NN assays_NNS ;_: R&D_NP Systems_NPS )_) according_VBG to_TO the_DT manufacturer_NN 's_POS recommendations_NNS ._SENT Briefly_RB ,_, cell_NN lysate_NN samples_NNS were_VBD diluted_VBN with_IN incubation_NN buffer_NN in_IN 96-well_NN plates_NNS ,_, p-nitroaniline-labeled_JJ peptide_NN substrates_NNS specific_JJ for_IN the_DT individual_JJ caspases_NNS were_VBD added_VBN ,_, and_CC the_DT plates_NNS were_VBD incubated_VBN at_IN 37C_JJ for_IN 2_CD h_NN and_CC read_VB at_IN 405_CD nm_NN ._SENT Western_JJ blot_NN analysis_NN ._SENT |_SYM Lysates_NP of_IN RSV-infected_NP or_CC mock-infected_JJ cells_NNS were_VBD normalized_VBN for_IN protein_NN concentration_NN ,_, subjected_VBN to_TO electrophoresis_NN on_IN a_DT sodium_NN dodecyl_NN sulfate-4_NN to_TO 20_CD %_NN polyacrylamide_NN gel_NN ,_, transferred_VBN to_TO a_DT polyvinyl_NN difluoride_NN membrane_NN (_( Invitrogen_NP )_) ,_, and_CC analyzed_VBD by_IN incubation_NN with_IN rabbit_NN anti-Mcl-1_JJ antibodies_NNS (_( Santa_NP Cruz_NP Biotechnology_NP )_) at_IN a_DT 1:200_CD dilution_NN followed_VBN by_IN peroxidase-labeled_JJ goat_NN anti-rabbit_NN IgG_NP (_( WesternBreeze_NP ;_: Invitrogen_NP )_) according_VBG to_TO the_DT manufacturer_NN 's_POS recommendations_NNS ._SENT Immunohistochemical_JJ studies_NNS ._SENT |_SYM A549_NP cells_NNS were_VBD seeded_VBN on_IN glass_NN coverslips_NNS in_IN six-well_NN plates_NNS and_CC infected_VBN with_IN RSV_NP ._SENT At_IN different_JJ times_NNS postinfection_NN ,_, cells_NNS were_VBD rinsed_VBN with_IN phosphate-buffered_JJ saline_NN and_CC fixed_VBN with_IN 2_CD %_NN formaldehyde_NN at_IN room_NN temperature_NN for_IN 10_CD min_NN ,_, which_WDT was_VBD followed_VBN by_IN two_CD washes_VBZ with_IN phosphate-buffered_JJ saline_NN ._SENT To_TO detect_VB Mcl-1_NP protein_NN ,_, cells_NNS were_VBD incubated_VBN with_IN a_DT 1:50_CD dilution_NN of_IN human_JJ Mcl-1-specific_NP rabbit_NN antibody_NN (_( Santa_NP Cruz_NP Biotechnology_NP )_) ,_, and_CC this_DT was_VBD followed_VBN by_IN staining_VBG with_IN a_DT 1:400_CD dilution_NN of_IN FITC-conjugated_JJ donkey_NN anti-rabbit_NN antibody_NN (_( Jackson_NP Immunoresearch_NP Laboratories_NPS ,_, West_NP Grove_NP ,_, Pa._NP )_) ._SENT To_TO visualize_VB nuclei_NNS ,_, cells_NNS were_VBD stained_VBN with_IN the_DT fluorescent_JJ DNA-intercalating_NN dye_NN 4,6-diamidino-2-phenylindole_NP (_( DAPI_NP )_) (_( 1_CD mug/ml_NN )_) for_IN 30_CD min_NN at_IN room_NN temperature_NN ._SENT Analysis_NN of_IN soluble_JJ TRAIL_NN in_IN cell_NN media_NNS ._SENT |_SYM The_DT level_NN of_IN TRAIL_NP in_IN medium_NN was_VBD determined_VBN using_VBG TRAIL_NP ActivELISA_NP (_( Imgenex_NP ,_, San_NP Diego_NP ,_, Calif._NP )_) according_VBG to_TO the_DT manufacturer_NN 's_POS recommendations_NNS ._SENT Briefly_RB ,_, a_DT 96-well_NN plate_NN was_VBD covered_VBN with_IN anti-TRAIL_JJ polyclonal_JJ antibodies_NNS ,_, blocked_VBN with_IN bovine_JJ serum_NN albumin_NN ,_, and_CC incubated_VBD with_IN cell_NN media_NNS or_CC standard_JJ dilutions_NNS of_IN recombinant_JJ soluble_JJ TRAIL_NN ._SENT Soluble_JJ TRAIL_NN captured_VBN on_IN the_DT plate_NN was_VBD then_RB detected_VBN by_IN TRAIL-specific_JJ detecting_VBG antibody_NN followed_VBN by_IN incubation_NN with_IN alkaline_JJ phosphatase-conjugated_JJ secondary_JJ antibody_NN and_CC color_NN reaction_NN with_IN p-nitrophenyl_NN phosphate_NN ._SENT Optical_JJ density_NN was_VBD measured_VBN at_IN 405_CD nm_NN and_CC compared_VBN with_IN those_DT for_IN the_DT standard_JJ dilutions_NNS ._SENT Sensitization_NN of_IN RSV-infected_JJ cells_NNS to_TO apoptosis_NN induced_VBN by_IN TRAIL_NP ._SENT |_SYM A549_NP cells_NNS were_VBD infected_VBN with_IN RSV_NP ._SENT After_IN incubation_NN at_IN 37C_JJ for_IN the_DT various_JJ times_NNS indicated_VBN in_IN Results_NNS ,_, synthetic_JJ TRAIL_NN was_VBD added_VBN to_TO a_DT final_JJ concentration_NN of_IN 500_CD or_CC 250_CD ng/ml_NNS with_IN or_CC without_IN a_DT TRAIL-specific_JJ antibody_NN (_( 2_CD mug/ml_NN )_) that_WDT increased_VBD the_DT ability_NN of_IN TRAIL_NP to_TO induce_VB apoptosis_NN (_( both_CC reagents_NNS from_IN Alexis_NP Corporation_NP ,_, San_NP Diego_NP ,_, Calif._NP )_) ._SENT The_DT level_NN of_IN apoptosis_NN was_VBD quantitated_VBN by_IN annexin_NN V_NN staining_VBG followed_VBN by_IN flow_NN cytometry_NN analysis_NN ._SENT RSV_NP replication_NN in_IN primary_JJ lung_NN epithelial_JJ cells_NNS ._SENT |_SYM One_CD possible_JJ factor_NN in_IN the_DT inconsistency_NN in_IN results_NNS from_IN previous_JJ studies_NNS of_IN RSV-induced_JJ apoptosis_NN was_VBD the_DT use_NN of_IN established_VBN cell_NN lines_NNS for_IN most_JJS of_IN the_DT published_VBN experiments_NNS ._SENT We_PP therefore_RB evaluated_VBD RSV_NP infection_NN of_IN primary_JJ NHBE_NP and_CC primary_JJ human_JJ SAEC_NP in_IN addition_NN to_TO two_CD transformed_VBN human_JJ cell_NN lines_NNS ,_, A549_NP and_CC HEp-2_NP ._SENT The_DT A549_NP line_NN originated_VBN from_IN type_NN II_NP alveolar_JJ adenocarcinoma_NN cells_NNS ,_, and_CC the_DT HEp-2_NP line_NN originally_RB consisted_VBD of_IN laryngeal_JJ epidermal_JJ carcinoma_NN cells_NNS but_CC now_RB is_VBZ available_JJ commercially_RB as_IN a_DT line_NN that_WDT is_VBZ mixed_VBN with_IN HeLa_NP cervical_JJ carcinoma_NN cells_NNS due_JJ to_TO cross-contamination_NN ._SENT As_RB will_MD be_VB seen_VBN later_RBR ,_, results_NNS obtained_VBD with_IN the_DT A549_NP cells_NNS generally_RB resembled_VBD those_DT of_IN the_DT primary_JJ cells_NNS ,_, whereas_IN this_DT often_RB was_VBD not_RB the_DT case_NN with_IN HEp-2_JJ cells_NNS ._SENT The_DT NHBE_NP and_CC SAEC_NP cells_NNS were_VBD compared_VBN to_TO A549_NP cells_NNS for_IN the_DT ability_NN to_TO support_VB the_DT replication_NN of_IN RSV_NP ._SENT With_IN regard_NN to_TO release_VB of_IN the_DT virus_NN into_IN the_DT medium_NN ,_, the_DT A549_NP cells_NNS appeared_VBD to_TO lag_VB behind_IN the_DT primary_JJ cells_NNS at_IN the_DT 12-_CD and_CC 24-h_JJ points_NNS ,_, but_CC by_IN 48_CD h_NN the_DT titer_NN of_IN virus_NN released_VBN from_IN A549_NP cells_NNS was_VBD similar_JJ to_TO that_DT for_IN the_DT primary_JJ cells_NNS ._SENT With_IN regard_NN to_TO cell-associated_JJ virus_NN ,_, the_DT A549_NP cells_NNS lagged_VBN behind_IN the_DT primary_JJ cells_NNS at_IN 12_CD h_NN ,_, and_CC at_IN 24_CD and_CC 48_CD h_NN there_RB was_VBD a_DT consistent_JJ range_NN of_IN titers_NNS ,_, with_IN that_IN of_IN the_DT NHBE_NP cells_NNS being_VBG the_DT highest_JJS ,_, followed_VBN by_IN those_DT of_IN the_DT SAEC_NP and_CC A549_NP cells_NNS ._SENT Thus_RB ,_, each_DT of_IN the_DT cultures_NNS supported_VBD efficient_JJ RSV_NP replication_NN ,_, although_IN there_EX were_VBD cell-specific_JJ differences_NNS in_IN kinetics_NNS and_CC efficiency_NN of_IN virus_NN release_NN ._SENT Following_VBG RSV_NP infection_NN of_IN NHBE_NP cells_NNS ,_, cell_NN rounding_VBG was_VBD observed_VBN in_IN a_DT small_JJ fraction_NN of_IN cells_NNS at_IN 12_CD h_NN postinfection_NN ,_, followed_VBN by_IN more_JJR extensive_JJ cell_NN rounding_VBG and_CC some_DT syncytium_NN formation_NN at_IN the_DT later_JJR time_NN points_NNS ._SENT In_IN SAEC_NP ,_, extensive_JJ cell_NN rounding_VBG and_CC some_DT syncytium_NN formation_NN started_VBD at_IN 12_CD h._NN In_IN A549_NP cells_NNS ,_, significant_JJ changes_NNS were_VBD not_RB observed_VBN at_IN 12_CD and_CC 24_CD h_NN postinfection_NN ,_, but_CC extensive_JJ syncytium_NN formation_NN and_CC cells_NNS rounding_VBG started_VBN at_IN 48_CD h._NN Generally_RB ,_, the_DT appearance_NN of_IN morphological_JJ changes_NNS in_IN monolayers_NNS of_IN the_DT three_CD cell_NN types_NNS correlated_VBD well_RB with_IN accumulation_NN of_IN the_DT infectious_JJ virus_NN in_IN cells_NNS and_CC media_NNS ,_, with_IN SAEC_NP being_VBG the_DT most_RBS sensitive_JJ and_CC A549_JJ the_DT least_JJS sensitive_JJ to_TO RSV_NP infection_NN ._SENT Also_RB ,_, A549_NP cells_NNS exhibited_VBD greater_JJR syncytium_NN formation_NN and_CC less_JJR cell_NN rounding_VBG than_IN the_DT primary_JJ cells_NNS ._SENT These_DT cytopathic_JJ effects_NNS likely_RB reflect_VBP a_DT combination_NN of_IN direct_JJ virus-mediated_JJ damage_NN and_CC cell-mediated_JJ apoptosis_NN ._SENT Cell_NN rounding_VBG is_VBZ associated_VBN with_IN ,_, but_CC is_VBZ not_RB specific_JJ for_IN ,_, apoptosis_NN ,_, while_IN syncytium_NN formation_NN is_VBZ mediated_VBN by_IN the_DT viral_JJ F_NN protein_NN but_CC can_MD amplify_VB apoptotic_JJ signals_NNS ._SENT RSV_NP induces_VBZ apoptosis_NN in_IN A549_NP and_CC primary_JJ lung_NN epithelial_JJ cells_NNS ._SENT |_SYM To_TO monitor_VB apoptosis_NN more_RBR directly_RB ,_, RSV-infected_NP NHBE_NP ,_, SAEC_NP and_CC A549_NP cells_NNS were_VBD analyzed_VBN by_IN staining_VBG with_IN annexin_NP V_CD ._SENT Annexin_NP V_NN has_VBZ a_DT high_JJ affinity_NN for_IN membrane_NN phospholipid_NN phosphatidylserine_NN (_( reviewed_VBN in_IN reference_NN )_) ,_, which_WDT is_VBZ translocated_VBN from_IN the_DT inner_JJ to_TO the_DT outer_JJ leaflet_NN of_IN the_DT plasma_NN membrane_NN at_IN an_DT early_JJ stage_NN of_IN apoptosis_NN ._SENT In_IN A549_NP cells_NNS ,_, there_EX was_VBD little_RB staining_VBG above_IN that_DT of_IN the_DT control_NN cells_NNS at_IN 24_CD h_NN ,_, but_CC by_IN 48_CD h_NN there_RB was_VBD extensive_JJ staining_VBG ._SENT In_IN NHBE_NP cells_NNS ,_, there_EX was_VBD a_DT moderate_JJ increase_NN in_IN the_DT percentage_NN of_IN apoptotic_JJ cells_NNS at_IN 24_CD h_NN ,_, and_CC there_EX was_VBD a_DT significant_JJ increase_NN (_( to_TO 55_CD %_NN )_) at_IN 48_CD h._NN In_IN SAEC_NP cells_NNS ,_, a_DT more_RBR rapid_JJ increase_NN in_IN the_DT percentage_NN of_IN apoptotic_JJ cells_NNS was_VBD observed_VBN ,_, with_IN approximately_RB 70_CD %_NN of_IN the_DT cells_NNS staining_VBG at_IN 24_CD h._NN The_DT percentages_NNS of_IN annexin_NP V-positive_NP mock-infected_VBD NHBE_NP and_CC SAEC_NP were_VBD higher_JJR than_IN that_DT of_IN A549_NP cells_NNS ,_, likely_RB due_JJ to_TO a_DT lower_JJR viability_NN of_IN the_DT primary_JJ cells_NNS in_IN vitro_NN ._SENT Thus_RB ,_, apoptosis_NN measured_VBN by_IN annexin_NN V_NN staining_VBG generally_RB paralleled_VBN or_CC followed_VBN the_DT production_NN of_IN infectious_JJ virus_NN and_CC the_DT appearance_NN of_IN gross_JJ morphological_JJ changes_NNS noted_VBD in_IN Fig._NN ._SENT Annexin_NN V_NN staining_VBG of_IN cells_NNS infected_VBN with_IN UV-inactivated_NP RSV_NP was_VBD essentially_RB equivalent_JJ to_TO that_DT of_IN the_DT uninfected_JJ control_NN ,_, indicating_VBG that_IN RSV_NP replication_NN is_VBZ necessary_JJ for_IN the_DT induction_NN of_IN apoptosis_NN ._SENT As_IN a_DT comparison_NN ,_, cells_NNS infected_VBN in_IN parallel_NN with_IN influenza_NN A_DT virus_NN exhibited_VBD a_DT somewhat_RB lower_JJR level_NN of_IN apoptosis_NN than_IN those_DT infected_JJ with_IN RSV_NP ._SENT Apoptosis_NN in_IN A549_NP cells_NNS also_RB was_VBD monitored_VBN by_IN the_DT TUNEL_NP assay_NN ,_, which_WDT detects_VBZ DNA_NN fragmentation_NN and_CC thus_RB measures_VBZ a_DT downstream_JJ step_NN in_IN apoptosis_NN ._SENT Positive_JJ TUNEL_NP staining_VBG was_VBD observed_VBN at_IN 48_CD and_CC 72_CD h_NN postinfection_NN ,_, but_CC not_RB at_IN 24_CD h_NN ,_, which_WDT correlates_VBZ with_IN the_DT results_NNS of_IN annexin_NN V_NN staining_VBG ._SENT In_IN situ_NN staining_VBG of_IN RSV-infected_NP A549_NP cells_NNS with_IN the_DT fluorescent_JJ DNA-intercalating_NN dye_NN DAPI_NP demonstrated_VBD strong_JJ condensation_NN of_IN chromatin_NN ,_, a_DT characteristic_JJ apoptotic_JJ change_NN ,_, in_IN a_DT small_JJ fraction_NN (_( <10_JJ %_NN )_) of_IN RSV-infected_JJ cells_NNS at_IN 48_CD h_NN postinfection_NN but_CC not_RB at_IN the_DT earlier_JJR time_NN points_NNS (_( not_RB shown_VBN )_) ._SENT RSV_NP induces_VBZ activation_NN of_IN initiator_NN caspases_NNS 8_CD ,_, 9_CD ,_, and_CC 10_CD and_CC effector_NN caspases_NNS 3_CD ,_, 6_CD ,_, and_CC 7_CD ._SENT |_SYM Total_JJ caspase_NN activation_NN in_IN RSV-infected_JJ cells_NNS was_VBD studied_VBN with_IN FITC-conjugated_NP VAD-FMK_NP ,_, which_WDT binds_VBZ irreversibly_RB to_TO activated_VBN caspases_NNS ._SENT A549_NP cells_NNS were_VBD mock_JJ infected_JJ or_CC infected_VBN with_IN RSV_NP for_IN 12_CD ,_, 24_CD ,_, or_CC 48_CD h_NN ;_: placed_VBN in_IN suspension_NN by_IN treatment_NN with_IN trypsin_NN ;_: washed_VBN ;_: stained_VBN with_IN FITC-VAD-FMK_NP ;_: and_CC assayed_VBN by_IN flow_NN cytometry_NN ._SENT At_IN 12_CD h_NN postinfection_NN ,_, the_DT number_NN of_IN FITC-VAD-FMK-positive_JJ cells_NNS was_VBD the_DT same_JJ in_IN RSV-_NP and_CC mock-infected_JJ cells_NNS ._SENT At_IN 24_CD h_NN a_DT small_JJ increase_NN in_IN the_DT number_NN of_IN the_DT positive_JJ cells_NNS was_VBD observed_VBN in_IN RSV-infected_NP but_CC not_RB mock-infected_JJ cells_NNS ;_: at_IN 48_CD h_NN approximately_RB 50_CD %_NN of_IN RSV-infected_JJ cells_NNS were_VBD positive_JJ ,_, whereas_IN uninfected_JJ control_NN cells_NNS did_VBD not_RB show_VB an_DT increase_NN in_IN staining_VBG ._SENT RPAs_NNS were_VBD used_VBN to_TO monitor_VB the_DT levels_NNS of_IN caspase_NN mRNAs_NNS in_IN RSV-infected_NP NHBE_NP ,_, SAEC_NP ,_, and_CC A549_NP and_CC HEp-2_NP cells_NNS ._SENT Marked_JJ increases_NNS in_IN the_DT levels_NNS of_IN mRNAs_NNS encoding_VBG initiator_NN caspases_NNS 8_CD and_CC 10_CD and_CC effector_NN caspases_NNS 3_CD ,_, 6_CD ,_, and_CC 7_CD were_VBD detected_VBN in_IN the_DT primary_JJ NHBE_NP and_CC SAEC_NP at_IN the_DT earliest_JJS time_NN point_NN analyzed_VBN (_( 12_CD h_NN )_) ._SENT Marked_JJ increases_NNS also_RB were_VBD observed_VBN for_IN each_DT of_IN these_DT caspase_NN mRNAs_NNS in_IN A549_JJ cells_NNS by_IN 24_CD h_NN and_CC ,_, especially_RB ,_, 48_CD h_NN except_IN for_IN caspase_NN 6_CD mRNA_NN ,_, which_WDT was_VBD significantly_RB increased_VBN only_RB at_IN 72_CD h._NN In_IN contrast_NN ,_, in_IN HEp-2_JJ cells_NNS there_EX was_VBD only_RB a_DT modest_JJ ,_, twofold_JJ increase_NN in_IN the_DT levels_NNS of_IN mRNA_NN for_IN caspases_NNS 10_CD ,_, 3_CD ,_, and_CC 6_CD ,_, and_CC there_EX was_VBD no_DT change_NN for_IN the_DT mRNAs_NNS for_IN caspase_NN 8_CD and_CC 7_CD ._SENT The_DT increases_NNS in_IN caspases_NNS 3_CD ,_, 8_CD ,_, and_CC 6_CD in_IN A549_NP cells_NNS were_VBD accompanied_VBN by_IN increase_NN in_IN the_DT corresponding_JJ enzymatic_JJ activities_NNS ;_: caspases_NNS 7_CD and_CC 10_CD were_VBD not_RB assayed_VBN ._SENT Caspase_NN 9_CD mRNA_NNS was_VBD not_RB detectable_JJ in_IN NHBE_NP and_CC SAEC_NP cells_NNS ,_, while_IN RSV_NP infection_NN of_IN A549_NP and_CC HEp-2_NP cells_NNS induced_VBD a_DT small_JJ (_( up_RB to_TO twofold_JJ )_) increase_NN in_IN caspase_NN 9_CD mRNA_NN (_( data_NNS not_RB shown_VBN )_) ._SENT The_DT lack_NN of_IN caspase_NN 9_CD mRNA_NNS detectable_JJ by_IN RPA_NP in_IN the_DT primary_JJ cells_NNS might_MD be_VB due_JJ to_TO a_DT low_JJ level_NN of_IN transcription_NN of_IN this_DT gene_NN ._SENT However_RB ,_, caspase_NN 9_CD enzymatic_JJ activity_NN was_VBD detected_VBN in_IN A549_NP cells_NNS beginning_VBG 36_CD h_NN postinfection_NN ._SENT No_DT increase_NN in_IN caspase_NN 2_CD and_CC 5_CD mRNA_NNS was_VBD detected_VBN with_IN RSV_NP infection_NN (_( not_RB shown_VBN )_) ._SENT Thus_RB ,_, RSV_NP infection_NN resulted_VBD in_IN up-regulation_NN of_IN mRNA_NN for_IN caspases_NNS 8_CD and_CC 10_CD ,_, which_WDT are_VBP initiator_NN caspases_NNS associated_VBN with_IN the_DT death_NN receptor_NN pathway_NN ;_: weak_JJ up-regulation_NN of_IN caspase_NN 9_CD ,_, an_DT initiator_NN caspase_NN associated_VBN with_IN the_DT mitochondrial_JJ pathway_NN ;_: and_CC up-regulation_NN of_IN caspases_NNS 3_CD ,_, 6_CD ,_, and_CC 7_CD ,_, which_WDT are_VBP effector_NN caspases_NNS utilized_VBN by_IN either_DT pathway_NN ._SENT RSV_NP induces_VBZ expression_NN of_IN pro-_NN and_CC antiapoptotic_JJ proteins_NNS of_IN the_DT Bcl-2_NP family_NN ._SENT |_SYM The_DT Bcl-2_NP family_NN contains_VBZ a_DT number_NN of_IN pro-_NN and_CC antiapoptotic_JJ factors_NNS whose_WP$ balance_NN can_MD play_VB a_DT role_NN in_IN the_DT decision_NN to_TO initiate_VB apoptosis_NN ._SENT RNase_NP protection_NN demonstrated_VBD up-regulation_NN of_IN a_DT number_NN of_IN pro-_NN and_CC antiapoptotic_JJ Bcl-2_JJ family_NN members_NNS in_IN response_NN to_TO RSV_NP infection_NN ._SENT mRNA_NNS encoding_VBG three_CD proapoptotic_JJ members_NNS ,_, Bid_NP ,_, Bax_NP and_CC Bak_NP ,_, was_VBD up-regulated_JJ two-_NN to_TO sevenfold_JJ in_IN RSV-infected_NP NHBE_NP ,_, SAEC_NP ,_, and_CC A549_NP cells_NNS ,_, whereas_IN only_JJ Bak_NP was_VBD up-regulated_VBN in_IN HEp-2_JJ cells_NNS ._SENT Up-regulation_NP also_RB was_VBD observed_VBN for_IN antiapoptotic_JJ members_NNS of_IN the_DT Bcl-2_NP family_NN ._SENT mRNA_NN for_IN Mcl-1_NP was_VBD strongly_RB up-regulated_JJ in_IN RSV-infected_NP NHBE_NP ,_, SAEC_NP ,_, and_CC A549_NP and_CC HEp-2_NP cells_NNS ._SENT The_DT up-regulation_NN of_IN Mcl-1_NP mRNA_NP was_VBD detected_VBN at_IN 12_CD h_NN for_IN NHBE_NP and_CC SAEC_NP cells_NNS and_CC 24_CD h_NN for_IN A549_NP cells_NNS ,_, which_WDT were_VBD the_DT earliest_JJS times_NNS tested_VBD ,_, and_CC by_IN 16_CD to_TO 24_CD h_NN for_IN HEp-2_JJ cells_NNS ._SENT In_IN RSV-infected_JJ primary_JJ cells_NNS ,_, Mcl-1_NP mRNA_NP reached_VBD levels_NNS that_WDT were_VBD 200_CD to_TO 400_CD %_NN of_IN the_DT amount_NN of_IN the_DT abundant_JJ GAPDH_NP (_( glyceraldehyde-3-phosphate_NN dehydrogenase_NN )_) mRNA_NN ,_, representing_VBG an_DT increase_NN of_IN up_RB to_TO 10-fold_NN ._SENT An_DT increase_NN in_IN mRNA_NN for_IN two_CD other_JJ antiapoptotic_JJ Bcl-2_NP family_NN members_NNS ,_, Bcl-W_NP and_CC Bcl-xL_NP ,_, also_RB was_VBD observed_VBN in_IN all_DT four_CD cell_NN cultures_NNS in_IN response_NN to_TO RSV_NP infection_NN ,_, although_IN the_DT increase_NN was_VBD less_RBR marked_VBN in_IN HEp-2_JJ cells_NNS ._SENT Also_RB ,_, the_DT level_NN of_IN these_DT mRNAs_NNS relative_JJ to_TO GADPH_NP mRNA_NP was_VBD less_JJR than_IN for_IN Mcl-1_NP ._SENT Up-regulation_NN of_IN mRNA_NN for_IN Bfl-1_NP ,_, another_DT antiapoptotic_JJ member_NN of_IN Bcl-2_NP family_NN was_VBD detected_VBN in_IN RSV-infected_NP A549_NP cells_NNS but_CC not_RB in_IN the_DT other_JJ cell_NN lines_NNS (_( not_RB shown_VBN )_) ._SENT The_DT accumulation_NN of_IN Mcl-1_NP protein_NN in_IN RSV-infected_NP A549_NP cells_NNS was_VBD analyzed_VBN at_IN 12_CD and_CC 24_CD h_NN postinfection_NN by_IN intracellular_JJ staining_VBG and_CC flow_NN cytometry_NN and_CC Western_JJ blotting_VBG ._SENT Flow_NN cytometry_NN analysis_NN demonstrated_VBD a_DT slight_JJ increase_NN in_IN the_DT median_JJ expression_NN of_IN Mcl-1_NP protein_NN at_IN 12_CD h_NN and_CC significant_JJ (_( P_NN <_SYM 0.001_CD )_) increase_NN in_IN Mcl-1_NP at_IN 24_CD h._NN Western_JJ blotting_VBG showed_VBD elevated_JJ levels_NNS of_IN the_DT Mcl-1_NP protein_NN at_IN 12_CD and_CC 24_CD h_NN post-RSV_NN infection_NN ._SENT The_DT increase_NN in_IN Mcl-1_NP protein_NN was_VBD also_RB detected_VBN by_IN immunohistochemistry_NN at_IN 12_CD and_CC 24_CD h_NN postinfection_NN ._SENT RSV_NP induces_VBZ production_NN of_IN TRAIL_NP in_IN infected_JJ cells_NNS ._SENT |_SYM RPAs_NP with_IN NHBE_NP and_CC SAEC_NP primary_JJ cells_NNS and_CC the_DT A549_NP cell_NN line_NN showed_VBD a_DT strong_JJ up-regulation_NN of_IN TRAIL_NP mRNA_NP ,_, whereas_IN no_DT increase_NN was_VBD observed_VBN in_IN HEp-2_JJ cells_NNS (_( not_RB shown_VBN )_) ._SENT TRAIL_NN is_VBZ a_DT member_NN of_IN the_DT TNF_NP family_NN and_CC ,_, together_RB with_IN its_PP$ functional_JJ receptors_NNS DR4_NP and_CC DR5_NP ,_, comprises_VBZ one_CD of_IN the_DT death_NN receptor_NN pathways_NNS for_IN apoptosis_NN ._SENT The_DT up-regulation_NN of_IN TRAIL_NP mRNA_NP was_VBD particularly_RB strong_JJ in_IN primary_JJ NHBE_NP and_CC SAEC_NP ,_, where_WRB it_PP increased_VBD from_IN the_DT low_JJ level_NN seen_VBN in_IN mock-_NN or_CC UV-RSV-infected_JJ cell_NN controls_NNS to_TO a_DT level_NN that_WDT was_VBD within_IN 55_CD to_TO 75_CD %_NN of_IN GAPDH_NP mRNA_NP ._SENT TRAIL_NN mRNA_NN also_RB was_VBD induced_VBN in_IN A549_NP cells_NNS ,_, but_CC its_PP$ abundance_NN relative_JJ to_TO GADPH_NP mRNA_NP was_VBD nearly_RB 10-fold_JJ lower_JJR than_IN in_IN primary_JJ cells_NNS ._SENT In_IN each_DT of_IN the_DT three_CD cell_NN types_NNS ,_, up-regulation_NN of_IN TRAIL_NP mRNA_NP was_VBD detected_VBN at_IN the_DT earliest_JJS time_NN point_NN tested_VBN (_( 12_CD h_NN for_IN primary_JJ cells_NNS and_CC 24_CD h_NN for_IN A549_NP cells_NNS )_) ._SENT The_DT expression_NN of_IN transmembrane_JJ TRAIL_NP protein_NN on_IN the_DT cell_NN surface_NN was_VBD quantitated_VBN in_IN mock-infected_JJ and_CC RSV-infected_JJ A549_JJ cells_NNS by_IN flow_NN cytometry_NN ._SENT An_DT increase_NN in_IN the_DT number_NN of_IN TRAIL-positive_JJ cells_NNS was_VBD observed_VBN at_IN 48_CD and_CC 72_CD h_NN after_IN RSV_NP infection_NN but_CC not_RB at_IN 24_CD h_NN postinfection_NN ._SENT TRAIL_NN also_RB can_MD be_VB expressed_VBN in_IN a_DT soluble_JJ ,_, truncated_JJ form_NN that_IN results_NNS from_IN proteolytic_JJ cleavage_NN of_IN the_DT ectodomain_NN from_IN the_DT transmembrane_NN anchor_NN ._SENT However_RB ,_, soluble_JJ TRAIL_NN in_IN the_DT medium_NN of_IN RSV-infected_NP or_CC mock-infected_JJ cells_NNS was_VBD not_RB detected_VBN by_IN an_DT antigen-capture_NN enzyme-linked_JJ immunosorbent_JJ assay_NN that_WDT had_VBD a_DT lower_JJR limit_NN of_IN detection_NN of_IN 40_CD pg/ml_NN (_( data_NNS not_RB shown_VBN )_) ._SENT RSV_NP induces_VBZ expression_NN of_IN TRAIL_NP receptors_NNS DR4_NP and_CC DR5_NP ._SENT |_SYM mRNA_NN encoding_VBG the_DT two_CD principal_JJ functional_JJ receptors_NNS for_IN TRAIL_NP ,_, DR4_NP and_CC DR5_NP ,_, was_VBD quantified_VBN by_IN RPA_NP ._SENT In_IN NHBE_NP ,_, both_DT DR4_NP and_CC DR5_NP mRNAs_NNS were_VBD strongly_RB up-regulated_JJ by_IN 12_CD h_NN postinfection_NN and_CC remained_VBD elevated_JJ at_IN 24_CD and_CC 48_CD h_NN ,_, with_IN peak_NN levels_NNS of_IN 35_CD %_NN (_( for_IN DR4_NP )_) and_CC 95_CD %_NN (_( for_IN DR5_NP )_) of_IN that_DT of_IN GAPDH_NP mRNA_NP ._SENT In_IN SAEC_NP ,_, DR4_NP and_CC DR5_NP mRNAs_NNS were_VBD markedly_RB elevated_VBN at_IN 12_CD h_NN but_CC diminished_VBN thereafter_RB ,_, with_IN the_DT peak_NN levels_NNS approximately_RB 50_CD and_CC 130_CD %_NN ,_, respectively_RB ,_, that_IN of_IN GAPDH_NP mRNA_NP ._SENT In_IN A549_NP cells_NNS ,_, the_DT levels_NNS of_IN DR4_NP and_CC DR5_NP mRNA_NP increased_VBD steadily_RB at_IN 24_CD ,_, 48_CD ,_, and_CC 72_CD h_NN ,_, but_CC the_DT levels_NNS relative_JJ to_TO GAPDH_NP mRNA_NP were_VBD substantially_RB lower_JJR than_IN for_IN primary_JJ cells_NNS ._SENT In_IN HEp-2_JJ cells_NNS ,_, the_DT up-regulation_NN of_IN DR4_NP or_CC DR5_NP mRNA_NP in_IN response_NN to_TO RSV_NP infection_NN was_VBD twofold_JJ or_CC less_RBR ,_, and_CC the_DT level_NN of_IN expression_NN was_VBD much_RB lower_JJR than_IN for_IN primary_JJ or_CC A549_JJ cells_NNS ._SENT We_PP also_RB quantified_VBD the_DT levels_NNS of_IN TRAIL_NP decoy_NN receptor_NN 1_CD (_( DcR1_NP )_) and_CC DcR2_NP )_) mRNAs_NNS ,_, which_WDT can_MD bind_VB TRAIL_NP and_CC block_VB its_PP$ effects_NNS ;_: no_DT detectable_JJ increase_NN in_IN these_DT mRNAs_NNS was_VBD detected_VBN after_IN RSV_NP infection_NN in_IN any_DT of_IN the_DT cells_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT Expression_NN of_IN DR4_NP and_CC DR5_NP proteins_NNS on_IN the_DT surface_NN of_IN RSV-infected_NP A549_NP cells_NNS was_VBD assayed_VBN by_IN flow_NN cytometry_NN ._SENT Up-regulation_NN of_IN DR4_NP was_VBD detected_VBN at_IN 48_CD h_NN and_CC increased_VBN at_IN 72_CD h_NN postinfection_NN ._SENT Expression_NN of_IN DR5_NP in_IN RSV-infected_NP cells_NNS was_VBD elevated_VBN at_IN 24_CD ,_, 48_CD ,_, and_CC 72_CD h._NNS Thus_RB ,_, RSV_NP infection_NN up-regulates_VBZ the_DT expression_NN of_IN DR4_NP and_CC DR5_NP receptors_NNS for_IN TRAIL_NP on_IN the_DT surface_NN of_IN cells_NNS ._SENT We_PP also_RB observed_VBD an_DT increase_NN in_IN the_DT expression_NN of_IN Fas_NP mRNA_NP after_IN RSV_NP infection_NN (_( data_NNS not_RB shown_VBN )_) ,_, consistent_JJ with_IN the_DT results_NNS of_IN O'Donnell_NP et_FW al._FW ._SENT Up-regulation_NN of_IN Fas_NP was_VBD observed_VBN in_IN NHBE_NP ,_, SAEC_NP ,_, and_CC A549_NP cells_NNS ,_, but_CC not_RB in_IN HEp-2_JJ cells_NNS ._SENT Infection_NN of_IN primary_JJ cells_NNS with_IN RSV_NP resulted_VBD in_IN a_DT 2-_CD to_TO 6-fold_JJ increase_NN in_IN Fas_NP mRNA_NP ,_, while_IN infection_NN of_IN A549_NP cells_NNS resulted_VBD in_IN a_DT 2-_CD to_TO 12-fold_NN increase_NN ;_: these_DT values_NNS were_VBD about_RB 2_CD to_TO 20_CD %_NN that_IN of_IN GAPDH_NP mRNA_NP (_( data_NN not_RB shown_VBN )_) ._SENT RSV_NP sensitizes_VBZ cells_NNS to_TO apoptosis_NN induced_VBN by_IN TRAIL_NP ._SENT |_SYM Increased_JJ surface_NN expression_NN of_IN the_DT DR4_NP and_CC DR5_NP TRAIL_NP receptors_NNS can_MD sensitize_VB a_DT cell_NN to_TO apoptotic_JJ killing_NN by_IN exogenous_JJ TRAIL_NP ,_, which_WDT is_VBZ present_JJ on_IN the_DT surface_NN of_IN a_DT variety_NN of_IN immune_JJ cells_NNS ,_, including_VBG natural_JJ killer_NN cells_NNS ,_, CD4+_NP T_NN lymphocytes_NNS ,_, macrophages_NNS ,_, and_CC dendritic_JJ cells_NNS (_( ,_, -_: ,_, ,_, )_) ,_, and_CC which_WDT also_RB can_MD be_VB released_VBN as_IN a_DT secreted_VBN soluble_JJ protein_NN ._SENT To_TO determine_VB whether_IN RSV_NP infection_NN resulted_VBD in_IN an_DT increased_VBN sensitivity_NN to_TO TRAIL-mediated_JJ apoptosis_NN ,_, A549_NP cells_NNS were_VBD infected_VBN with_IN RSV_NP ,_, and_CC 24_CD h_NN later_RBR ,_, exogenous_JJ TRAIL_NN was_VBD added_VBN to_TO the_DT medium_NN to_TO a_DT final_JJ concentration_NN of_IN 500_CD ng/ml_NNS together_RB with_IN a_DT TRAIL-specific_JJ antibody_NN that_WDT enhances_VBZ TRAIL_NN activity_NN by_IN cross-linking_VBG and_CC increasing_VBG its_PP$ local_JJ concentration_NN ._SENT Before_IN TRAIL_NN and_CC anti-TRAIL_NN antibody_NN were_VBD added_VBN ,_, there_EX was_VBD no_DT difference_NN in_IN cell_NN morphology_NN between_IN RSV-infected_NP and_CC noninfected_JJ cells_NNS ;_: however_RB ,_, within_IN 3_CD h_NN after_IN the_DT addition_NN of_IN TRAIL_NN plus_CC anti-TRAIL_NN antibody_NN ,_, the_DT RSV-infected_NP cells_NNS exhibited_VBD dramatic_JJ cytopathic_JJ effects_NNS ._SENT RSV-infected_JJ cells_NNS treated_VBN with_IN TRAIL_NP plus_CC anti-TRAIL_NP antibody_NN rounded_VBD up_RP ,_, and_CC within_IN 5_CD h_NN after_IN the_DT addition_NN ,_, most_JJS of_IN the_DT cells_NNS were_VBD floating_VBG in_IN the_DT medium_NN (_( Fig._NN ,_, left_VBD panels_NNS )_) ._SENT No_DT significant_JJ changes_NNS were_VBD observed_VBN in_IN uninfected_JJ cells_NNS treated_VBN in_IN parallel_NN with_IN TRAIL_NN plus_CC anti-TRAIL_NN antibody_NN ,_, nor_CC in_IN untreated_JJ RSV-infected_JJ cells_NNS ._SENT Also_RB ,_, addition_NN of_IN anti-TRAIL_NN antibody_NN alone_RB to_TO uninfected_JJ or_CC RSV-infected_JJ cells_NNS had_VBD no_DT effect_NN (_( not_RB shown_VBN )_) ._SENT Addition_NN of_IN TRAIL_NP to_TO RSV-infected_JJ cells_NNS in_IN the_DT absence_NN of_IN the_DT TRAIL-specific_NP antibody_NN induced_VBD very_RB little_JJ cytopathic_JJ effect_NN after_IN 5_CD h_NN of_IN incubation_NN ;_: following_VBG a_DT further_JJR 3_CD h_NN of_IN incubation_NN ,_, the_DT amount_NN of_IN cytopathic_JJ effect_NN was_VBD increased_VBN but_CC remained_VBN considerably_RB less_RBR than_IN that_DT observed_VBN after_IN 5_CD h_NN of_IN treatment_NN with_IN TRAIL_NP plus_CC TRAIL-specific_NP antibody_NN (_( not_RB shown_VBN )_) ._SENT To_TO quantify_VB the_DT percentage_NN of_IN apoptotic_JJ cells_NNS ,_, the_DT cell_NN monolayers_NNS were_VBD harvested_VBN together_RB with_IN floating_JJ cells_NNS ,_, stained_VBN with_IN annexin_NP V-FITC_NP ,_, and_CC analyzed_VBD by_IN flow_NN cytometry_NN (_( Fig._NN ,_, right_JJ panels_NNS )_) ._SENT The_DT percentage_NN of_IN annexin_JJ V-positive_JJ cells_NNS in_IN the_DT three_CD negative_JJ controls_NNS ,_, namely_RB ,_, mock-infected_JJ cells_NNS ,_, mock-infected_JJ cells_NNS treated_VBN with_IN TRAIL_NP plus_CC anti-TRAIL_NN antibody_NN ,_, and_CC RSV-infected_JJ cells_NNS without_IN TRAIL_NN or_CC anti-TRAIL_NN antibody_NN ,_, was_VBD 24_CD to_TO 26_CD %_NN ._SENT In_IN contrast_NN ,_, 42_CD %_NN of_IN RSV-infected_JJ cells_NNS treated_VBN with_IN TRAIL_NP plus_CC anti-TRAIL_NN antibody_NN were_VBD annexin_JJ V_CD positive_NN ._SENT Thus_RB ,_, RSV_NP strongly_RB sensitizes_VBZ cells_NNS to_TO rapid_JJ TRAIL-induced_JJ apoptosis_NN ._SENT The_DT time_NN course_NN of_IN acquisition_NN of_IN sensitivity_NN to_TO TRAIL-induced_JJ apoptosis_NN during_IN the_DT first_JJ 25_CD h_NN of_IN RSV_NP infection_NN was_VBD studied_VBN in_IN A549_NP cells_NNS ._SENT Cells_NNS were_VBD infected_VBN with_IN RSV_NP and_CC at_IN various_JJ times_NNS postinfection_NN were_VBD exposed_VBN to_TO TRAIL_NP (_( 250_CD ng/ml_NNS )_) plus_CC TRAIL-specific_JJ antibody_NN and_CC incubated_VBN for_IN an_DT additional_JJ 5_CD h_NN before_IN being_VBG collected_VBN and_CC analyzed_VBN for_IN annexin_NN V_NN staining_VBG ._SENT There_EX was_VBD a_DT steady_JJ increase_NN in_IN sensitivity_NN to_TO exogenous_JJ TRAIL_NN with_IN increasing_VBG time_NN after_IN infection_NN ,_, with_IN a_DT marked_JJ increase_NN in_IN sensitivity_NN evident_JJ by_IN 11_CD h_NN postinfection_NN ,_, long_RB before_IN the_DT production_NN of_IN infectious_JJ progeny_NN virus_NN ._SENT We_PP examined_VBD the_DT induction_NN of_IN apoptosis_NN following_VBG RSV_NP infection_NN of_IN two_CD types_NNS of_IN human_JJ primary_JJ pulmonary_JJ epithelial_JJ cells_NNS ,_, namely_RB ,_, NHBE_NP and_CC SAEC_NP ,_, and_CC two_CD cell_NN lines_NNS commonly_RB used_VBN for_IN RSV_NP studies_NNS ,_, namely_RB ,_, A549_NP cells_NNS and_CC HEp-2_JJ cells_NNS ._SENT RPAs_NNS were_VBD used_VBN to_TO quantify_VB the_DT mRNAs_NNS for_IN 33_CD common_JJ apoptosis_NN factors_NNS ,_, which_WDT identified_VBD a_DT number_NN of_IN pro-_NN and_CC antiapoptotic_JJ factors_NNS that_WDT were_VBD up-regulated_VBN in_IN response_NN to_TO RSV_NP infection_NN ._SENT In_IN general_JJ ,_, results_NNS obtained_VBD with_IN the_DT two_CD primary_JJ cells_NNS were_VBD in_IN close_JJ agreement_NN ._SENT Results_NNS with_IN A549_NP cells_NNS also_RB were_VBD generally_RB in_IN good_JJ agreement_NN with_IN those_DT of_IN the_DT primary_JJ cells_NNS ,_, although_IN sometimes_RB the_DT magnitude_NN of_IN the_DT response_NN was_VBD reduced_VBN ;_: in_IN contrast_NN ,_, the_DT transcriptional_JJ profile_NN of_IN pro-_NN and_CC antiapoptotic_JJ response_NN in_IN HEp-2_NP cells_NNS often_RB was_VBD distinct_JJ ,_, suggesting_VBG that_IN HEp-2_NP cells_NNS are_VBP not_RB a_DT reliable_JJ substrate_NN for_IN such_JJ studies_NNS ._SENT The_DT results_NNS with_IN the_DT primary_JJ and_CC A549_JJ cells_NNS showed_VBD that_IN RSV_NP induces_VBZ apoptosis_NN in_IN a_DT large_JJ fraction_NN of_IN infected_JJ cells_NNS ,_, although_IN the_DT programmed_JJ degenerative_JJ changes_NNS usually_RB occurred_VBD late_RB in_IN infection_NN compared_VBN to_TO virus_NN production_NN ._SENT RSV_NP infection_NN was_VBD shown_VBN to_TO strongly_RB up-regulate_VB the_DT components_NNS of_IN the_DT TRAIL_NP death_NN receptor_NN pathway_NN and_CC strongly_RB sensitized_VBD the_DT cells_NNS to_TO apoptosis_NN mediated_VBD by_IN exogenous_JJ TRAIL_NN ._SENT Evidence_NN was_VBD found_VBN of_IN activation_NN of_IN components_NNS of_IN both_CC the_DT death_NN receptor_NN and_CC mitochondrial_JJ apoptotic_JJ pathways_NNS ._SENT In_IN addition_NN ,_, there_EX was_VBD strong_JJ up-regulation_NN of_IN antiapoptotic_JJ factors_NNS ,_, notably_RB Mcl-1_NP ,_, which_WDT might_MD account_VB for_IN the_DT apparent_JJ slow_JJ onset_NN in_IN the_DT execution_NN of_IN apoptosis_NN ._SENT TRAIL_NN is_VBZ an_DT apoptosis-inducing_NN ligand_NN that_WDT belongs_VBZ to_TO the_DT TNF_NP superfamily_NN ,_, together_RB with_IN TNF_NP alpha_NN and_CC FAS_NP ligand_NN (_( FasL_NP or_CC CD95_NP )_) ._SENT TRAIL_NN is_VBZ a_DT type_NN II_NP transmembrane_NN protein_NN that_WDT can_MD undergo_VB cleavage_NN to_TO release_VB a_DT C-terminal_JJ soluble_JJ domain_NN that_WDT can_MD form_VB trimers_NNS ._SENT Both_CC the_DT soluble_JJ and_CC membrane-associated_JJ forms_NNS can_MD induce_VB apoptosis_NN ,_, although_IN in_IN the_DT present_JJ study_NN we_PP were_VBD unable_JJ to_TO detect_VB soluble_JJ TRAIL_NN in_IN medium_NN from_IN RSV-infected_JJ cells_NNS ._SENT Expression_NN of_IN TRAIL_NP has_VBZ been_VBN detected_VBN in_IN a_DT number_NN of_IN human_JJ tissues_NNS ,_, most_RBS predominantly_RB in_IN spleen_NN ,_, lungs_NNS ,_, and_CC prostate_NN ;_: inducers_NNS include_VBP alpha/beta_NN and_CC gamma_NN interferons_NNS ._SENT TRAIL_NN ,_, like_IN TNF_NP alpha_NN and_CC FasL_NP ,_, is_VBZ an_DT inducer_NN of_IN the_DT death_NN receptor_NN (_( external_JJ )_) pathway_NN of_IN apoptosis_NN and_CC is_VBZ involved_VBN in_IN apoptosis_NN induced_VBN by_IN reovirus_NN ,_, adenovirus_NN ,_, and_CC cytomegalovirus_NN ;_: in_IN addition_NN ,_, measles_NN virus_NN induces_VBZ TRAIL_NN production_NN by_IN dendritic_JJ cells_NNS ._SENT TRAIL_NN can_MD bind_VB to_TO five_CD different_JJ receptors_NNS :_: DR4_NP and_CC DR5_NP are_VBP functional_JJ receptors_NNS that_WDT mediate_VBP apoptotic_JJ responses_NNS and_CC were_VBD strongly_RB up-regulated_JJ by_IN RSV_NP infection_NN ,_, and_CC DcR1_NP ,_, DcR2_NP ,_, and_CC osteoprotegrin_NN are_VBP decoy_NN receptors_NNS that_WDT bind_VBP TRAIL_NN without_IN inducing_VBG apoptosis_NN and_CC were_VBD not_RB detected_VBN in_IN the_DT present_JJ study_NN ._SENT Binding_VBG of_IN TRAIL_NP to_TO DR1_NP or_CC DR2_NP leads_VBZ to_TO formation_NN of_IN death-inducing_NN signaling_VBG complex_NN consisting_VBG of_IN (_( i_NP )_) DR4_NP or_CC DR5_NP trimers_NNS ,_, (_( ii_NNS )_) an_DT adaptor_NN molecule_NN such_JJ as_IN FAS-associating_JJ prot_NN 